River Wealth Advisors LLC Gilead Sciences, Inc. Transaction History

River Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $9,254 - $10,367	-148 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$60.54 - $79.0 $24,881 - $32,469	-411 Reduced 73.52%	148 $9,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $35,354 - $39,144	-496 Reduced 47.01%	559 $43,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $68,448 - $79,842	1,055 New	1,055 $75,000

1,993

993M

10.1M

8.85M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on River Wealth Advisors LLC with notifications on news.